We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.69%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90B
AUM Growth
-$2.64B
(-2.9%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
2,101
New
60
Increased
1,058
Reduced
623
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$327M |
| 2 |
Broadcom
AVGO
|
+$315M |
| 3 |
Mastercard
MA
|
+$262M |
| 4 |
Intuit
INTU
|
+$226M |
| 5 |
Digital Realty Trust
DLR
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
| 3 |
WCN
Waste Connections
WCN
|
+$141M |
| 4 |
NextEra Energy
NEE
|
+$134M |
| 5 |
Cadence Design Systems
CDNS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Industrials | 16.63% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 8.12% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Truist Financial
TFC
$64.3B
| $34.9M | 0.04% |
848,209
-37,025
| -4% | -$1.65M |
|
377
NVR
NVR
$16.8B
| $34.8M | 0.04% |
4,810
+300
| +7% | +$2.28M |
|
378
Ameriprise Financial
AMP
$49.6B
| $34.3M | 0.04% |
70,888
+5,427
| +8% | +$2.85M |
|
379
KKR & Co
KKR
$99.3B
| $33.8M | 0.04% |
292,131
+17,934
| +7% | +$2.47M |
|
380
Edwards Lifesciences
EW
$53.5B
| $33.5M | 0.04% |
462,516
+86,771
| +23% | +$6.21M |
|
381
Cencora
COR
$60.4B
| $33.4M | 0.04% |
120,109
-5,908
| -5% | -$1.48M |
|
382
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
| $33.3M | 0.04% |
+369,205
| New | +$32.9M |
|
383
Chipotle Mexican Grill
CMG
$41.4B
| $33.1M | 0.04% |
658,545
-71,732
| -10% | -$3.9M |
|
384
iShares Global Financials ETF
IXG
$697M
| $33M | 0.04% |
322,100
+53,700
| +20% | +$5.45M |
|
385
Yum! Brands
YUM
$40.6B
| $32.4M | 0.04% |
205,907
-65,878
| -24% | -$9.49M |
|
386
Integer Holdings
ITGR
$4.26B
| $32.3M | 0.04% |
273,708
+15,783
| +6% | +$2.07M |
|
387
Sonoco
SON
$5.74B
| $31.3M | 0.03% |
662,740
+71,528
| +12% | +$3.38M |
|
388
Royal Caribbean
RCL
$82.3B
| $31.3M | 0.03% |
152,311
+6,464
| +4% | +$1.53M |
|
389
Brookfield
BN
$109B
| $31.2M | 0.03% |
892,979
-196,453
| -18% | -$7.43M |
|
390
iShares Core S&P 500 ETF
IVV
$904B
| $31.1M | 0.03% |
55,800
-72,992
| -57% | -$43.1M |
|
391
Canadian Imperial Bank of Commerce
CM
$110B
| $31.1M | 0.03% |
553,270
+190,439
| +52% | +$11.5M |
|
|
ETNB
392
DELISTED
89bio
ETNB
| $30.6M | 0.03% |
4,204,887
+1,197,853
| +40% | +$10.5M |
|
393
Full Truck Alliance
YMM
$9.6B
| $30.4M | 0.03% |
2,378,463
+29,274
| +1% | +$353K |
|
394
Yum China
YUMC
$16.4B
| $30.3M | 0.03% |
582,059
+25,702
| +5% | +$1.23M |
|
395
Target
TGT
$69.4B
| $30.2M | 0.03% |
289,418
+15,719
| +6% | +$1.96M |
|
396
IDEAYA Biosciences
IDYA
$3.55B
| $30.1M | 0.03% |
1,838,764
-102,507
| -5% | -$2.18M |
|
397
West Pharmaceutical
WST
$24.9B
| $30.1M | 0.03% |
134,351
+16,880
| +14% | +$4.65M |
|
398
Gulfport Energy Corp
GPOR
$2.98B
| $30M | 0.03% |
163,016
-12,597
| -7% | -$2.29M |
|
399
Biogen
BIIB
$30.5B
| $30M | 0.03% |
217,530
-76,163
| -26% | -$10.9M |
|
400
Canadian Pacific Kansas City
CP
$81.5B
| $29.9M | 0.03% |
426,330
-119,779
| -22% | -$9.11M |
|
Similar funds
Pictet Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pictet Asset Management held 2,101 positions worth $90B, down 2.9% from $92.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Pictet Asset Management's Q1 2025 filing shows 60 new, 1,058 increased, 623 reduced and 92 closed positions. Its largest new stake was Verona Pharma: 703,063 shares worth $44.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $187M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2025 buy was Verona Pharma: 703,063 shares worth $44.6M.
- Pictet Asset Management added most to Synopsys in Q1 2025, an estimated $327M increase.
- Pictet Asset Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $187M.
- Pictet Asset Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2025, selling an estimated $46.5M.
- Pictet Asset Management's ten largest holdings make up 17% of its $90B portfolio in Q1 2025.
- Pictet Asset Management opened 60 new positions and closed 92 in Q1 2025.
- Pictet Asset Management's portfolio value fell 2.9% quarter-over-quarter to $90B.
Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.